Enoblituzumab, previously known as TJ-271 or MGA271, represents a unique antibody specific to CD33, the surface protein found predominantly on blood populations. This antibody works as an bispecific therapy, at once https://liviajiww235934.activoblog.com/52666298/enoblituzumab-a-deep-dive-into-tj-271-and-mga271